75A50126C00010↗

Name: 75A50126C00010: This Acquisition Will Allow Barda to Invest Project Bioshield Funds for Late-Stage Clinical Development, Regulatory Approval for 2-Pam Autoinjectors (As a Drug/Device Combination Product) to Treat Organophosphate (Op) Poisoning, Including Nerve Agent
Creator: SpendQuery
License: https://www.usa.gov/government-works

THIS ACQUISITION WILL ALLOW BARDA TO INVEST PROJECT BIOSHIELD FUNDS FOR LATE-STAGE CLINICAL DEVELOPMENT, REGULATORY APPROVAL FOR 2-PAM AUTOINJECTORS (AS A DRUG/DEVICE COMBINATION PRODUCT) TO TREAT ORGANOPHOSPHATE (OP) POISONING, INCLUDING NERVE AGENT

Definitive Contract · Office of Assistant Secretary for Preparedness and Response · to Kaleo, Inc. (UEI LBM4GLJNDK31) · data as of 2026-10-22

Obligated to date$96.06M1 action

Current value$96.06Mwith options exercised

Potential value$340.91Mif every option is used

Period2026-09-30 → 2034-12-31current end date

What it is

Product or service: Health R&D Services; Health Care Services; Basic Research (PSC AN11)
Industry: Research and Development in Biotechnology (Except Nanobiotechnology) (NAICS 541714)
Contracting office: Barda - Aspr / Daappo / Barda Dcma (75A501)
Competition: Full and open competition · 3 offers received
Pricing: Cost plus fixed fee
How it was bought: Standalone contract
Solicitation: 75A50126R00002
Where the work is: Henrico, VA · district VA-01

Obligations by fiscal year

FY2026$96.06M

SpendQuery holds FY2023 on; earlier years are on USAspending.gov.

Subcontractors: where the money went next

No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.

Every action

1 action since 2026-09-28. Each is a modification or amendment with the money it added or took back.

Date	Modification	Kind	Amount	What the agency wrote
2026-09-28	0		$96.06M	THIS ACQUISITION WILL ALLOW BARDA TO INVEST PROJECT BIOSHIELD FUNDS FOR LATE-STAGE CLINICAL DEVELOPMENT, REGULATORY APPROVAL FOR 2-PAM AUTOINJECTORS (AS A DRUG/DEVICE COMBINATION PRODUCT) TO TREAT ORGANOPHOSPHATE (OP) POISONING, INCLUDING NERVE AGENT

Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-22). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗

Putting the award page together from the records…